Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection

Bibliographic Details
Title: Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection
Authors: Marta Vomero, Cristiana Barbati, Tania Colasanti, Alessandra Ida Celia, Mariangela Speziali, Federica Maria Ucci, Claudia Ciancarella, Fabrizio Conti, Cristiano Alessandri
Source: Frontiers in Pharmacology, Vol 11 (2020)
Publisher Information: Frontiers Media S.A., 2020.
Publication Year: 2020
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: SARS-CoV-2, CoViD-19, autophagy, lymphocytes, cytokines, Therapeutics. Pharmacology, RM1-950
More Details: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the novel coronavirus, causing coronavirus disease 2019 (COVID-19). During virus infection, several pro-inflammatory cytokines are produced, leading to the “cytokine storm.” Among these, interleukin (IL)-6, tumor necrosis factor‐α (TNF‐α), and IL-1β seem to have a central role in the progression and exacerbation of the disease, leading to the recruitment of immune cells to infection sites. Autophagy is an evolutionarily conserved lysosomal degradation pathway involved in different aspects of lymphocytes functionality. The involvement of IL-6, TNF‐α, and IL-1β in autophagy modulation has recently been demonstrated. Moreover, preliminary studies showed that SARS-CoV-2 could infect lymphocytes, playing a role in the modulation of autophagy. Several anti-rheumatic drugs, now proposed for the treatment of COVID-19, could modulate autophagy in lymphocytes, highlighting the therapeutic potential of targeting autophagy in SARS-CoV-2 infection.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1663-9812
Relation: https://www.frontiersin.org/articles/10.3389/fphar.2020.569849/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2020.569849
Access URL: https://doaj.org/article/ce71cd916b3241e3832787d5c0b09f04
Accession Number: edsdoj.71cd916b3241e3832787d5c0b09f04
Database: Directory of Open Access Journals
More Details
ISSN:16639812
DOI:10.3389/fphar.2020.569849
Published in:Frontiers in Pharmacology
Language:English